Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
about
Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials.Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy.Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies.
P2860
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@ast
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@en
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@nl
type
label
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@ast
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@en
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@nl
prefLabel
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@ast
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@en
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@nl
P2860
P356
P1476
Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus
@en
P2093
Theodoros Voulgaris
Vassilios A Sevastianos
P2860
P304
P356
10.1155/2016/7629318
P407
P577
2016-01-01T00:00:00Z